Inhibition of NF-κB induces a switch from CD95L-dependent to CD95L-independent and JNK-mediated apoptosis in T cells

FEBS Letters

Volumn 584, Issue 22, 2010, Pages 4679-4688

  Kießling, Michael K ^a   Linke, Björn ^a   Brechmann, Markus ^a   Süss, Dorothee ^a   Krammer, Peter H ^a   Gülow, Karsten ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

Apoptosis; JNK; MAP kinase phosphatase; Reactive oxygen species; T cell receptor signaling

Indexed keywords

CASPASE; FAS LIGAND; FLICE INHIBITORY PROTEIN; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE 7; PROTEIN BCL 2; PROTEIN BCL XL; STRESS ACTIVATED PROTEIN KINASE; T LYMPHOCYTE RECEPTOR; X LINKED INHIBITOR OF APOPTOSIS;

APOPTOSIS; ARTICLE; CELL DEATH; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVATION; ENZYME ACTIVE SITE; ENZYME ACTIVITY; ENZYME INHIBITION; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; MOLECULAR DYNAMICS; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; T LYMPHOCYTE; UPREGULATION;

APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; DUAL-SPECIFICITY PHOSPHATASES; ENZYME ACTIVATION; FAS LIGAND PROTEIN; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; I-KAPPA B KINASE; IONOMYCIN; JNK MITOGEN-ACTIVATED PROTEIN KINASES; JURKAT CELLS; MEMBRANE PROTEINS; MITOGEN-ACTIVATED PROTEIN KINASE PHOSPHATASES; NF-KAPPA B; PROTO-ONCOGENE PROTEINS; REACTIVE OXYGEN SPECIES; RECEPTORS, ANTIGEN, T-CELL; SIGNAL TRANSDUCTION; T-LYMPHOCYTES;

EID: 78249276849     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.febslet.2010.10.047     Document Type: Article

References (34)

1. Krueger A., Fas S.C., Baumann S., Krammer P.H. The role of CD95 in the regulation of peripheral T-cell apoptosis. Immunol. Rev. 2003, 193:58-69.
2. Krammer P.H., Arnold R., Lavrik I.N. Life and death in peripheral T cells. Nat. Rev. Immunol. 2007, 7:532-542.
3. Baud V., Karin M. Is NF-kappaB a good target for cancer therapy? Hopes and pitfalls. Nat. Rev. Drug Discov. 2009, 8:33-40.
4. Karin M., Lin A. NF-kappaB at the crossroads of life and death. Nat. Immunol. 2002, 3:221-227.
5. Brenner D., Golks A., Kiefer F., Krammer P.H., Arnold R. Activation or suppression of NFkappaB by HPK1 determines sensitivity to activation-induced cell death. EMBO J. 2005, 24:4279-4290.
6. Mora A.L., et al. Antiapoptotic function of NF-kappaB in T lymphocytes is influenced by their differentiation status: roles of Fas, c-FLIP, and Bcl-xL. Cell Death Differ. 2003, 10:1032-1044.
7. Kiessling M.K., Klemke C.D., Kaminski M.M., Galani I.E., Krammer P.H., Gulow K. Inhibition of constitutively activated nuclear factor-kappaB induces reactive oxygen species- and iron-dependent cell death in cutaneous T-cell lymphoma. Cancer Res. 2009, 69:2365-2374.
8. Kamata H., Honda S., Maeda S., Chang L., Hirata H., Karin M. Reactive oxygen species promote TNFalpha-induced death and sustained JNK activation by inhibiting MAP kinase phosphatases. Cell 2005, 120:649-661.
9. Pham C.G., et al. Ferritin heavy chain upregulation by NF-kappaB inhibits TNFalpha-induced apoptosis by suppressing reactive oxygen species. Cell 2004, 119:529-542.
10. Devadas S., Zaritskaya L., Rhee S.G., Oberley L., Williams M.S. Discrete generation of superoxide and hydrogen peroxide by T cell receptor stimulation: selective regulation of mitogen-activated protein kinase activation and fas ligand expression. J. Exp. Med. 2002, 195:59-70.
11. Gulow K., Kaminski M., Darvas K., Suss D., Li-Weber M., Krammer P.H. HIV-1 trans-activator of transcription substitutes for oxidative signaling in activation-induced T cell death. J. Immunol. 2005, 174:5249-5260.
12. Kaminski M., Kiessling M., Suss D., Krammer P.H., Gulow K. Novel role for mitochondria: protein kinase Ctheta-dependent oxidative signaling organelles in activation-induced T-cell death. Mol. Cell. Biol. 2007, 27:3625-3639.
13. Walczak H., Sprick M.R. Biochemistry and function of the DISC. Trends Biochem. Sci. 2001, 26:452-453.
14. Loewe R., et al. Dimethylfumarate inhibits TNF-induced nuclear entry of NF-kappa B/p65 in human endothelial cells. J. Immunol. 2002, 168:4781-4787.
15. Krammer P.H., Kaminski M., Kiessling M., Gulow K. No life without death. Adv. Cancer Res. 2007, 97C:111-138.
16. Kwon J., Devadas S., Williams M.S. T cell receptor-stimulated generation of hydrogen peroxide inhibits MEK-ERK activation and lck serine phosphorylation. Free Radic. Biol. Med. 2003, 35:406-417.
17. Tonks N.K. Redox redux: revisiting PTPs and the control of cell signaling. Cell 2005, 121:667-670.
18. Liu Y., Shepherd E.G., Nelin L.D. MAPK phosphatases - regulating the immune response. Nat. Rev. Immunol. 2007, 7:202-212.
19. Salojin K., Oravecz T. Regulation of innate immunity by MAPK dual-specificity phosphatases: knockout models reveal new tricks of old genes. J. Leukoc. Biol. 2007, 81:860-869.
20. Matsuguchi T., Musikacharoen T., Johnson T.R., Kraft A.S., Yoshikai Y. A novel mitogen-activated protein kinase phosphatase is an important negative regulator of lipopolysaccharide-mediated c-Jun N-terminal kinase activation in mouse macrophage cell lines. Mol. Cell. Biol. 2001, 21:6999-7009.
21. Tanoue T., Yamamoto T., Maeda R., Nishida E. A novel MAPK phosphatase MKP-7 acts preferentially on JNK/SAPK and p38 alpha and beta MAPKs. J. Biol. Chem. 2001, 276:26629-26639.
22. Groom L.A., Sneddon A.A., Alessi D.R., Dowd S., Keyse S.M. Differential regulation of the MAP, SAP and RK/p38 kinases by Pyst1, a novel cytosolic dual-specificity phosphatase. EMBO J. 1996, 15:3621-3632.
23. Mourey R.J., Vega Q.C., Campbell J.S., Wenderoth M.P., Hauschka S.D., Krebs E.G., Dixon J.E. A novel cytoplasmic dual specificity protein tyrosine phosphatase implicated in muscle and neuronal differentiation. J. Biol. Chem. 1996, 271:3795-3802.
24. Brenner D., et al. Caspase-cleaved HPK1 induces CD95L-independent activation-induced cell death in T and B lymphocytes. Blood 2007, 110:3968-3977.
25. Snow A.L., Oliveira J.B., Zheng L., Dale J.K., Fleisher T.A., Lenardo M.J. Critical role for BIM in T cell receptor restimulation-induced death. Biol. Direct 2008, 3:34.
26. Jin H.O., et al. Up-regulation of Bak and Bim via JNK downstream pathway in the response to nitric oxide in human glioblastoma cells. J. Cell. Physiol. 2006, 206:477-486.
27. Kirchhoff S., Muller W.W., Li-Weber M., Krammer P.H. Up-regulation of c-FLIP short and reduction of activation-induced cell death in CD28-costimulated human T cells. Eur. J. Immunol. 2000, 30:2765-2774.
28. Li-Weber M., Krammer P.H. The death of a T-cell: expression of the CD95 ligand. Cell Death Differ. 2002, 9:101-103.
29. Reth M. Hydrogen peroxide as second messenger in lymphocyte activation. Nat. Immunol. 2002, 3:1129-1134.
30. Droge W. Free radicals in the physiological control of cell function. Physiol. Rev. 2002, 82:47-95.
31. Franklin C.C., Kraft A.S. Conditional expression of the mitogen-activated protein kinase (MAPK) phosphatase MKP-1 preferentially inhibits p38 MAPK and stress-activated protein kinase in U937 cells. J. Biol. Chem. 1997, 272:16917-16923.
32. Noguchi T., Metz R., Chen L., Mattei M.G., Carrasco D., Bravo R. Structure, mapping, and expression of erp, a growth factor-inducible gene encoding a non-transmembrane protein tyrosine phosphatase, and effect of ERP on cell growth. Mol. Cell. Biol. 1993, 13:5195-5205.
33. Sun H., Charles C.H., Lau L.F., Tonks N.K. MKP-1 (3CH134), an immediate early gene product, is a dual specificity phosphatase that dephosphorylates MAP kinase in vivo. Cell 1993, 75:487-493.
34. Lei K., Davis R.J. JNK phosphorylation of Bim-related members of the Bcl2 family induces Bax-dependent apoptosis. Proc. Natl. Acad. Sci. USA 2003, 100:2432-2437.